Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abdominal, accelerated, accretion, acquiree, acute, Adrian, advisory, afamicel, Ali, alkaline, Allen, Alleva, alopecia, ALT, anaemia, Andrew, arose, ascribed, assay, AST, back, bargain, Behbahani, blood, Boston, breast, Cambridge, CEO, Chair, chill, cholangiocarcinoma, classification, colorectal, Commission, companion, composed, confirmatory, constipation, Construct, cough, count, CRS, customer, dataset, David, dehydrogenase, demonstrating, diagnostic, diarrhoea, dose, draft, dual, dyspnoea, dysuria, earlier, Elliot, embolism, escalation, evidence, explained, fatigue, favourable, febrile, feedback, fell, fixed, focussing, forma, Furey, Fusion, Garry, Goodwill, headache, Hegde, Hege, hematological, hematuria, hyperkalaemia, hypoalbuminaemia, hypokalaemia, hypotension, hypoxia, IGNYTE, Intensive, ipilimumab, John, Kristen, lack, lacrimation, lactate, Lawrence, leadership, legislation, lessee, leukemia, lot, LTFU, lymphocyte, malignant, margin, medial, Menzel, mesothelioma, method, mid, month, Mott, MPM, multiplied, myeloid, nausea, neutropenia, neutrophil, noncontrolling, noninfective, NSCLC, Opdivo, output, pain, pancreatic, PhD, phosphatase, pivotal, platelet, pleuritic, portion, PPQ, precede, Priti, pro, promise, provisional, pulmonary, pyrexia, qualification, rash, ratio, Rawcliffe, renal, rent, rental, senior, sensitive, side, Sigal, single, sponsorship, Squibb, standalone, sum, supplemental, survival, tachycardia, team, thromboplastin, transduced, triple, troponin, TRuC, undergoing, unfavorable, unmanageable, utilising, validation, vesting, vice, whilst, white, Yervoy
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view